Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial

• প্রধান লেখক: Ira N. Kalfus (লেখক), David Y. Graham (লেখক), Dennis S. Riff (লেখক), Raymond M. Panas (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2020-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Due to increasing resistance to commonly used antibiotics, the World Health Organization and Food and Drug Administration have advocated the development of new therapeutic regimens for <i>Helicobacter pylori</i> (<i>H. pylori</i>). This phase three, double-blind study (ERADIC...